
TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment
Introduction NK cell-based immunotherapy is being actively developed and researched as a strategy for treating AML, due to the immunosurveillance functions and antigen-independent cytotoxicity of NK cells.1 Disease relapse frequently occurs due to the …